0.10Open0.10Pre Close0 Volume3.23K Open Interest7.50Strike Price0.00Turnover205.61%IV68.51%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier12DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1330Delta0.1228Gamma45.10Leverage Ratio-0.0143Theta0.0002Rho6.00Eff Leverage0.0018Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics(APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
Watchlist.
$ZyVersa Therapeutics(ZVSA.US)$ $Roma Green Finance(ROMA.US)$ $Veru Inc(VERU.US)$ $Achilles Therapeutics(ACHL.US)$ $Gaxos.ai(GXAI.US)$ $Applied Therapeutics(APLT.US)$ $Sonder Holdings(SOND.US)$
📊⚡️📊
No comment yet